independently-verified examination of their supply chains . From the boardroom to the factory floor , employees must be educated to make these gradual changes . Rodger believes that pharmaceutical companies must understand their climate risks in order to become more sustainable .
“ Many companies have made Net Zero and decarbonisation targets the cornerstone of their sustainability strategy and while it ’ s an excellent place to start , Net Zero on its own is insufficient ,” explains Rodger . “ The other , equally important part of sustainability planning is physical risk – protecting physical assets , including manufacturing plants and distribution centres , from the effects of accelerating climate events .”
Cervest ’ s founder & CEO Iggy Bassi has warned that , regardless of hitting Net Zero , there will still be environmental problems that humanity must face .
“ Reaching Net Zero is vital to future climate stability , but even if we were to attain this goal tomorrow , decades of historic emissions mean that climate volatility is now locked into Earth ’ s system for years to come ,” Bassi said .
Cervest believes that it is critical for pharmaceutical businesses to understand the climate risks facing their built assets , in order for them to begin the clean energy transition .
23 %
Water Footprint data revealed that ‘ industry ’, including pharma manufacturing , accounted for 23 % of worldwide water usage
“ Thanks to recent scientific and computing advances , pharma leaders can self-screen assets for climate risk and use the resulting climate intelligence to assess climate risk at the portfolio and asset level , and feed those insights into decisionmaking ,” says Rodger . “ Cervest makes climate intelligence insights available ‘ on demand ’ to decision-makers through our EarthScan product . Pharma companies are using EarthScan to assess and quantify the climate risks impacting their assets – their own and those across their supply networks . EarthScan uniquely enables them to assess risk simultaneously across different timeframes , risk categories and climate scenarios . Using these insights , they can make informed adaptation decisions .”
How the pharmaceutical industry can become sustainable Boxes of medicine often come with an instruction leaflet in many different languages , but the patient only needs one . For those who buy the medicine on repeat , they may read the leaflet the first time they use it , but not on subsequent purchases . This means that most of the paper used in medicine box leaflets is unused – but
healthcare-digital . com 83